Novartis Investigative Site

Piacenza, Emilia-Romagna 29100

0 studies enrolling now · 2 studies all time

What they study most

Leukaemia, Lymphocytic, Chronic, Neoplasms, Gastrointestinal Tract

Studies at this site

• LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib — Completed
• Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy — Stopped early